Add like
Add dislike
Add to saved papers

Volumetric Graft Changes After Liver Transplantation - Evidence of Adaptation to Recipient Body Size.

INTRODUCTION: It is believed that whole liver grafts adjust their size to fit the body size of the recipient after transplantation, despite lack of evidence. The aim of this study was to test this hypothesis.

METHODS: This was a retrospective cohort study of 113 liver transplantations performed at Karolinska University Hospital. The cohort was divided based on graft volume-to-standard liver volume ratio (GV/SLV) into quartiles of small, mid and large grafts. Serial volumetric assessment was performed on the day of transplantation and at post-transplant check-ups early (<2 months) and late (9-13 months) after transplantation using computed tomography (CT) volumetry. Change in GV/SLV-ratio over time was analyzed with ANOVA repeated measures. A multiple regression model was used to investigate the influence of intraoperative blood flow, recipient body size, age and relative sickness on graft volume changes.

RESULTS: Between the three timepoints, mean GV/SLV-ratio adapted to: 0.55 -0.94 - 1.00 in small grafts (n=29, p<0.001); 0.87 - 1.18 - 1.13 in mid grafts (n=56, p<0.001); 1.11 - 1.51 - 1.18 in large grafts (n=28, p<0.001). Regression analysis showed a positive correlation between post-transplant graft growth and portal flow (β=1.18, p=0.005), arterial flow (β=0.17, p=0.001) and recipient body surface area (β=59.85, p<0.001). A negative correlation was observed for graft weight-to-recipient weight ratio (GRWR) (β=-33.12, p<0.001).

CONCLUSIONS: Grafts with initial GV/SLV-ratio<0.6 adapt towards the ideal volume for recipient body size one year after transplantation. The disparity between graft size relative to recipient body size, and the portal and arterial perfusion, influence volumetric graft changes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app